
Haplo Life Sciences Private Limited
About Haplo Life Sciences Private Limited
Data last updated:
Haplo Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 11 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2020PTC373068. Its GSTIN is 07AAFCH5388A1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Karuna Upadhyay and Dinesh Chandra Upadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. S – 3 S/F Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹19.38 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹22,210 (net margin -1.1%) and EBITDA of -₹22,210 (EBITDA margin -1.1%).
Company details
Contact details
Haplo Life Sciences Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No. S – 3 S/F Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Haplo Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Haplo Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Haplo Life Sciences Private Limited, buy the company report.
Financials of Haplo Life Sciences Private Limited
FY 2025 filings availableHaplo Life Sciences Private Limited reported revenue of ₹19.38 Lakh (down 65% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 65% in the latest year. EBITDA fell 263% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22,210 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹22,210 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.1% | ||||
| Net Profit Margin | -1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Haplo Life Sciences Private Limited, buy the company report.
Board of directors of Haplo Life Sciences Private Limited
Haplo Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karuna Upadhyay Also directs: Shiva Scientific Lifesciences Private Limited | Director | 11 Nov 2020 | 6 Years 0 Months | Current |
| Dinesh Chandra Upadhyay Also directs: Shiva Scientific Lifesciences Private Limited | Director | 11 Nov 2020 | 6 Years 0 Months | Current |
Peer comparison
Haplo Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Eilis Health Care Private Limited | ₹19.49 Lakh (FY 2023) | -22.0% | Mumbai, Maharashtra, India | |||
| Haplo Life Sciences Private Limitedthis company | ₹19.38 Lakh (FY 2025) | -₹22,210 | -1.1% | -65.0% | Delhi, India | |
| Vego & Thomson Infra-Tech (India) Private Limited | ₹19.37 Lakh (FY 2025) | -92.0% | Jhajjar, Haryana, India | |||
| New Sound Hearing Aid Private Limited | ₹19.29 Lakh (FY 2025) | -95.0% | Delhi, India |
To see the full peer comparison of Haplo Life Sciences Private Limited, buy the company report.
Auditor
Haplo Life Sciences Private Limited is audited by GHANSHYAM SURESH GUPTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GHANSHYAM SURESH GUPTA & ASSOCIATES | FY 2023 | 026525N |
Shareholding
The shareholding of Haplo Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Haplo Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Haplo Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Haplo Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Haplo Life Sciences Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Haplo Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCH5388A1ZN | Delhi | Active | 03 Dec 2020 |
To see the full GST registrations and return filing status of Haplo Life Sciences Private Limited, buy the company report.
Recent activity
Haplo Life Sciences Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Dinesh Chandra Upadhyay was appointed as Director on 11 Nov 2020.
Frequently asked questions
Haplo Life Sciences is an active private limited company based in Delhi, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 11 November 2020 (6+ years old) and is registered under CIN U51397DL2020PTC373068.
Haplo Life Sciences has 2 current directors:
- Karuna Upadhyay - Director
- Dinesh Chandra Upadhyay - Director
The latest financial statements of Haplo Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Haplo Life Sciences is 07AAFCH5388A1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Haplo Life Sciences is U51397DL2020PTC373068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Haplo Life Sciences was incorporated on 11 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Haplo Life Sciences by revenue are Eilis Health Care Private Limited, Vego & Thomson Infra-Tech (India) Private Limited, New Sound Hearing Aid Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Dinesh Chandra Upadhyay was appointed as Director on 11 Nov 2020. Karuna Upadhyay was appointed as Director on 11 Nov 2020.
The registered office of Haplo Life Sciences is at Shop No. S – 3 SF Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.
Haplo Life Sciences operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Haplo Life Sciences can be reached at its registered office: Shop No. S – 3 SF Plot No. – 11 Sector – 4 Mlu Pkt Manish Abhinav Plaza Dwarka, Delhi, India – 110078.

